|
Information on the MGH
Neurofibromatosis Clinic
2010
Clinical and
Research Report
|
|
Voice: (617) 724-7856
Fax: (617) 72-8769
|
|
|
|
Referrals
and Appointments:
To make an appointment
in the
NF clinic at MGH call
(617) 724-7856.
|
|
The
Neurofibromatosis
Clinic at MGH - Founded
in 1982 by Dr. Robert Martuza, the MGH NF Clinic was one of
the first to acknowledge the unique multi-disciplinary problems
that the NF patient and family face--and the vital role that
a dedicated clinic plays in the research community. The Neurofibromatosis
Clinic offers a comprehensive initial evaluation to all persons
in whom a diagnosis of neurofibromatosis has been suggested
or confirmed. In addition to a neurological examination this
includes a dermatological evaluation and referral for neuro-ophthalmological
evaluation and imaging studies. Many persons come to the clinic
with a diagnosis of "rule out neurofibromatosis"
and the role of the clinic is to clarify whether or not that
diagnosis can be made. Others come because they are a first
degree relative of an NF patient and are thus at 50-50 risk
for the disease. Because so much is now known about the natural
history and genetic risks of these diseases, it is always
important to make a clear diagnosis at the onset in any one
person.
Once a
diagnosis of NF or a related condition is established, the
staff works with the patient and family to devise a comprehensive
management plan. Many patients require no more than an annual
neurological evaluation and imaging or hearing evaluations.
Others have ongoing and complex medical issues such as the
timing of neurological surgery, or management of intractable
pain or progressive disability. Genetic counseling is relevant
at almost every visit, as genetic concerns evolve with patient's
life. The role of genetic counseling is also changing as our
abilities to make molecular diagnosis improve for both NF1
and NF2. Some patients choose to continue care in the NF clinic
and others take their management plan back to their own physicians
for follow up. In all cases, the results of the evaluation
are communicated to the patient's primary care physician and
any other care providors involved with the patient and family,
and the clinic staff is available to discuss questions with
care providors as needed.
What
is neurofibromatosis?
Neurofibromatosis
is a genetic disorder that causes people to develop tumors
of the nervous system. There are three major forms of neurofibroamtosis
(NF1, NF2, and schwannomatosis) and the manifestations vary
greatly between patients and families. NF1 (peripheral neurofibromatosis,
von Recklinghausen disease) is almost always apparent in infancy
and early childhood. Persons with NF1 develop multiple neurofibromas,
cafe au lait macules and Lisch nodules of the eye. Some people
with NF1 also have other manifestations such as learning disability,
macrocephaly, bony abnormalities and malignancy.
NF2 (central
neurofibromatosis, bilateral acoustic neurofibromatosis) is
usually not apparent until the teenage years. NF2 causes tumors
to develop on both nerves to the ears (bilateral vestibular
schwannomas or acoustic neuromas). Everyone with NF2 develops
bilateral vestibular schwannomas and everyone with bilateral
vestibular schwannomas has NF2.
Schwannomatosis
is a rare form of NF that has only recently been recognized.
People with schwannomatosis develop multiple schwannomas on
cranial, spinal and peripheral nerves--but they do not develop
vestibular tumors and do not go deaf. Affected individuals
usually have much greater problems with pain than with neurological
disability, although as with all forms of NF, schwannomatosis
may vary greatly between patients.
Because
both NF1 and NF2 and schwannomatosis are relatively rare disorders
that can cause a number of neurological and medical consequences,
a network of specialized NF clinics has been developed throughout
the world.
More
Information:
|